SEE H10.
Report
- Report Number
- 2015691-2020-14108
- Event Type
- Injury
- Date Received
- October 23, 2020
- Date of Event
- September 29, 2020
- Report Date
- September 29, 2020
- Manufacturer
- EDWARDS LIFESCIENCES
- Product Code
- DYE
- PMA / PMN Number
- SEE H10.
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TW
- Reporter Occupation
- PHYSICIAN
Narratives
H11. CORRECTED DATA: CORRECTED D4 SERIAL NUMBER TO ASKU. SERIAL NUMBER ORIGINALLY PROVIDED IS INVALID. SERIAL NUMBER REMAINS UNKNOWN AT THIS TIME.
ADDITIONAL MANUFACTURER NARRATIVE: THE DEVICE WAS NOT RETURNED TO EDWARDS FOR EVALUATION AS IT REMAINS IMPLANTED. ATTEMPTS TO RETRIEVE ADDITIONAL INFORMATION IS IN PROCESS. IF ADDITIONAL INFORMATION IS RECEIVED A SUPPLEMENTAL MDR WILL BE SUBMITTED. ALTHOUGH BIOPROSTHETIC VALVES HAVE BEEN PROVEN TO HAVE EXCELLENT LONG TERM DURABILITY, FAILURE DOES OCCUR IN A SMALL NUMBER OF VALVES. REPLACEMENT OF A BIOPROSTHETIC VALVE OVER TIME IS MORE LIKELY DUE TO STRUCTURAL VALVE DETERIORATION (SVD) WHICH OCCURS AS A RESULT OF STENOSIS (FROM CALCIFICATION OR HOST TISSUE OVERGROWTH), DEHISCENCE, FIBROSIS OR NON-CALCIFIC DEGENERATION AND/OR ENDOCARDITIS. THE CAUSE OF THE EVENT CANNOT BE DETERMINED. EDWARDS WILL CONTINUE TO REVIEW AND MONITOR ALL EVENTS. TRENDS ARE MONITORED ON A MONTHLY BASIS AND IF ACTION IS REQUIRED, APPROPRIATE INVESTIGATION WILL BE PERFORMED. THIS DEVICE IS NOT SOLD OR MARKETED IN THE UNITED STATES; HOWEVER, IT IS SIMILAR TO THE BRAND CARPENTIER-EDWARDS DURAFLEX LOW PRESSURE MITRAL BIOPROSTHESOS , MODEL# 6625LP, PMA# P870077.
EDWARDS RECEIVED NOTIFICATION THAT THIS PATIENT WITH A 31MM MITRAL PORCINE VALVE UNDERWENT INTERVENTION FOR A VALVE-IN-VALVE REPLACEMENT AFTER AN IMPLANT DURATION OF 13 YEARS AND 1 MONTH FOR UNKNOWN REASON.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1188328 | SEE H10. | REPLACEMENT HEART-VAVLE | DYE | EDWARDS LIFESCIENCES | SEE H10. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 64 YR | Hospitalization| L| R |